Introduction: Breast cancer is one of the most common types of cancer which causes death among women every year. More reports on breast cancer suggest that early diagnosis is important for improving clinical outcomes and overall survival in patients with breast cancer. Cancer testis antigens (CTAs) are considered as therapeutic targets, which are promising candidates in this field. In this context, we followed the expression of AKAP4 (cancer testis antigen that expressed in breast cancer tumors) in the peripheral blood as a possible diagnostic biomarker.
